Ohio State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ohio State University sits in the top decile of US sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count).

552 total trials 117 currently recruiting 319 completed early-phase tilt top decile by trial count

Ohio State University: 552 sponsored US clinical trials, 117 recruiting.

Ohio State University sponsors 552 registered US clinical trials on ClinicalTrials.gov, 117 of them currently recruiting, and 319 completed. 39 of these trials are in Phase 3-4 (later-stage) and 60 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Suicidal Ideation, with 8 trials.

Top-decile sponsor footprint

Ohio State University ranks in the top decile of sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 57/100

319 of 366 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

552 total, page 5 of 12

COMPLETED Phase 1

Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes

NCT05571397
COMPLETED NA

Accommodative Behaviors in Multifocal Contact Lenses

NCT06064617
COMPLETED NA

Developing a mHealth Simulation Platform for Youth

NCT05953532
COMPLETED Phase 4

Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)

NCT05922033
COMPLETED NA

Pair 2 Care: Peer Support for Caregivers of Black Americans Living With Dementia

NCT06064955
COMPLETED

Preoperative Cognitive Reserve in Older Surgical Patients: A Feasibility Study

NCT06245005
COMPLETED Phase 1

Tailoring OT and RD Services for Home-delivered Meal Clients

NCT06059404
COMPLETED NA

Optimizing Residential Treatment Gains for Adolescents

NCT05764369
TERMINATED Phase 4

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

NCT05741502
COMPLETED NA

Mindfulness in Motion Targeted to Sustaining the Mental and Physical Resilience of First Responders

NCT07502092
COMPLETED NA

Discrimination and Religious Experiences of Adult Muslimahs in Salaat

NCT06264011
COMPLETED NA

Low-GI Diet Vs High-GI Diet in Individuals with SCI

NCT05334342
COMPLETED

Comparing Two Surgical Techniques for Building up the Bone Where a Dental Implant is to be Placed

NCT06871657
COMPLETED Phase 1

Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment

NCT05880888
COMPLETED NA

Ketogenic Intervention in Depression

NCT06080932
COMPLETED NA

Stress and Hypertension in Dementia Caregivers

NCT05721482
COMPLETED NA

Evaluating a Web Delivered Behavioral Parent Training Intervention for Rural Parents of Children With Autism Spectrum Disorder

NCT05554198
COMPLETED Early Phase 1

Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder

NCT05656534
COMPLETED NA

Evaluation of Wear Experience With Daily Disposable and Monthly Replacement Toric Contact Lenses

NCT05580575
COMPLETED

Treatment Outcomes in PASC Patients With Neurocognitive Impairment

NCT07090564
COMPLETED NA

Incorporating Positive Affect Promoting Activities Into Cognitive Behavioral Therapies

NCT06432959
COMPLETED NA

Strategies for Coping With Negative Thoughts

NCT05566691
COMPLETED NA

Active Ingredients & Efficacy of Aquatic Therapy for Autistic Children

NCT05524753
TERMINATED Phase 4

Trial Comparing Three Single Dose Injections for Knee Osteoarthritis

NCT05492851
COMPLETED Phase 4

Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING)

NCT05248984
COMPLETED NA

Heartfulness Meditation (HFM) in Cyclic Vomiting Syndrome (CVS)

NCT05961995
COMPLETED Early Phase 1

The Response to Atropine Drops (RAD) Study

NCT05199597
COMPLETED Phase 2

Dilated Versus Non-Dilated Wavefront Corrections for Patients With Down Syndrome

NCT05059041
COMPLETED NA

Feasibility of Pediatric CIMT by Televideo

NCT05303883
COMPLETED

Characterizing Occupational Therapy Intervention for Children With Autism Spectrum Disorders

NCT05480605
COMPLETED NA

TrueRelief Efficacy for Post-cesarean Pain (ELECTRON)

NCT05250830
COMPLETED Phase 4

A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity

NCT05289869
COMPLETED NA

Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops

NCT05288582
COMPLETED NA

Follow-up Gun Study: Can Safety Videos Mitigate Interest in Guns in Children?

NCT05257837
COMPLETED NA

A Problem Solving Intervention for Post-ICU Cognitive Impairment in Older Adults

NCT03972384
COMPLETED

Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors

NCT05122000
COMPLETED Phase 2

Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD

NCT05107752
COMPLETED NA

Assessing the Effectiveness of Self- and Clinician-administered Crisis Response Planning for Suicide Risk

NCT04903431
COMPLETED

Nifedipine Dosing Daily vs Twice a Day for Pre-eclampsia With Severe Features (NOPPI)

NCT05096728
COMPLETED NA

Evaluation of Wear Experience With a Water Surface Daily Disposable Contact Lens

NCT05102383
COMPLETED NA

Penetrating the Classroom Social Network for Children With Language Impairment Via Peer Mediated Intervention

NCT06182033
COMPLETED NA

Move to Improve: Telehealth Exercise to Music for HD

NCT05270681
COMPLETED NA

Auditory Neural Function in Implanted Patients With Usher Syndrome

NCT04906135
COMPLETED NA

Aquatic Therapy for ASD

NCT05092321
COMPLETED NA

Pilot Study of Nursing Touch and Biobehavioral Stress

NCT05030233
COMPLETED NA

Patient Educational Video for Pelvic Organ Prolapse

NCT04996563
COMPLETED Phase 4

Research and Innovation to Stop E-cigarette/Vaping in Young Adults

NCT04974580
COMPLETED NA

Upper Extremity Function Before and After Hippotherapy in Children With Autism Spectrum Disorder and/or Cerebral Palsy

NCT06530680
COMPLETED NA

Achieving Nutritional Adequacy Of Vitamin K With An Egg/Plant-Based Food Pairing

NCT04286321
COMPLETED NA

Achieving Nutritional Adequacy Of Vitamin E With An Egg/Plant-Based Food Pairing

NCT04287816
← Previous Page 5 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 35
Phase 2 25
Phase 3 5
Phase 4 34

Therapeutic Areas

Suicidal Ideation 8
Anxiety 7
Obesity 6
Type 2 Diabetes 5
Pregnancy, High Risk 5
PreDiabetes 5
Suicide, Attempted 4
Alcohol Use Disorder 4
Depression 4
Endotoxemia 3

What is open in the Ohio State University pipeline

117 recruiting of 552 indexed (21% open); 319 completed (58%).

Phase mix: 39 late (III/IV) vs 60 early (I/II) (early-phase heavy).

Top condition: Suicidal Ideation (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ohio State University: open-pipeline peers nationwide

Peers matched on 552 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Ohio State UniversityAmgenMerck Sharp & DohmeVirginia Commonwealth UniversityOregon Health and Science UniversityUniversity of LouisvilleMedical College of WisconsinNova Southeastern UniversityColorado State University
Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 552 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Ohio State University page

552 registered trials is a research-attention snapshot, not an endorsement of Ohio State University or any single study.

  • 117 of Ohio State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Suicidal Ideation is the condition Ohio State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Suicidal Ideation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Ohio State University pipeline card: 552 registered trials from official public datasets.Report a data error.